IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SPOSITO, CARLO FERRUCCIO ALVISE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.158
AS - Asia 5.890
NA - Nord America 5.862
SA - Sud America 602
AF - Africa 107
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.526
DE - Germania 4.045
CN - Cina 1.958
IT - Italia 1.704
SG - Singapore 1.491
GB - Regno Unito 1.141
BD - Bangladesh 638
HK - Hong Kong 457
BR - Brasile 415
RU - Federazione Russa 392
FR - Francia 354
VN - Vietnam 338
SE - Svezia 306
IN - India 292
CA - Canada 229
ES - Italia 217
FI - Finlandia 190
NL - Olanda 184
IE - Irlanda 151
KR - Corea 132
TR - Turchia 108
JP - Giappone 107
AR - Argentina 88
ID - Indonesia 86
AU - Australia 65
MX - Messico 62
UA - Ucraina 58
DK - Danimarca 56
CH - Svizzera 53
BE - Belgio 45
TW - Taiwan 44
PT - Portogallo 38
PH - Filippine 36
GR - Grecia 35
AT - Austria 33
CO - Colombia 32
IQ - Iraq 30
PL - Polonia 26
PK - Pakistan 25
TH - Thailandia 24
ZA - Sudafrica 23
CL - Cile 22
NO - Norvegia 20
CI - Costa d'Avorio 18
SA - Arabia Saudita 17
IR - Iran 16
RO - Romania 16
MY - Malesia 15
EC - Ecuador 14
VE - Venezuela 14
BY - Bielorussia 12
EG - Egitto 11
HU - Ungheria 11
TN - Tunisia 11
PE - Perù 10
RS - Serbia 10
BG - Bulgaria 9
IL - Israele 9
JM - Giamaica 9
KE - Kenya 9
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EU - Europa 7
JO - Giordania 7
KZ - Kazakistan 7
MA - Marocco 7
UZ - Uzbekistan 7
AL - Albania 6
BH - Bahrain 6
DZ - Algeria 6
LT - Lituania 6
SI - Slovenia 6
AZ - Azerbaigian 5
BF - Burkina Faso 5
EE - Estonia 5
GT - Guatemala 5
HN - Honduras 5
LV - Lettonia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
GD - Grenada 4
MK - Macedonia 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
LB - Libano 3
LU - Lussemburgo 3
NI - Nicaragua 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
BS - Bahamas 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
GY - Guiana 2
HR - Croazia 2
LK - Sri Lanka 2
MD - Moldavia 2
Totale 21.666
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 3.710
Southend 946
Singapore 848
Dallas 671
Ashburn 537
Milan 428
Hong Kong 342
Chandler 318
San Jose 303
New York 234
Santa Clara 229
Beijing 214
Council Bluffs 202
Los Angeles 163
Hefei 150
Rome 150
Dublin 146
Princeton 141
Seattle 137
Houston 124
Helsinki 123
Wilmington 123
Guangzhou 107
Shanghai 102
The Dalles 102
Ann Arbor 99
Fairfield 99
Ho Chi Minh City 94
Buffalo 90
Lauterbourg 86
Bengaluru 85
Hanoi 82
Moscow 82
Redwood City 79
São Paulo 79
Dearborn 78
Toronto 77
Bologna 68
Madrid 66
Jakarta 63
Munich 60
Nanjing 60
Woodbridge 58
Boardman 54
Des Moines 53
Tianjin 53
Tokyo 53
Naples 52
Phoenix 51
Chicago 47
Hangzhou 47
Seoul 47
Paris 46
Buenos Aires 44
Columbus 43
Jinan 43
Shenzhen 42
London 41
Fuzhou 39
Ottawa 38
Istanbul 36
Berlin 33
Cambridge 33
Montreal 30
Wuhan 28
Athens 26
Atlanta 26
Florence 26
Hyderabad 25
Turin 25
Brussels 24
Chengdu 24
Melbourne 24
Verona 24
Nuremberg 23
Changsha 22
Lappeenranta 22
Zurich 22
Amsterdam 21
Bari 21
Central 21
Chennai 21
Shenyang 21
Nanchang 19
Washington 19
Abidjan 18
Cangzhou 18
Fremont 18
Zhengzhou 18
Barcelona 17
Delhi 17
Dong Ket 17
Jacksonville 17
Mumbai 17
Bogotá 16
Duncan 16
Grafing 16
Johannesburg 16
San Francisco 16
Boston 15
Totale 13.616
Salva come PNG Salva come JPEG
Nome #
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 1.492
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL) : a randomised, controlled, phase 2b/3 trial 917
Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal 501
Transplantation of autologous extracellular vesicles for cancer-specific targeting 496
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant 467
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study 428
Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava 414
Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors 367
Development of a prognostic scoring system for resectable hepatocellular carcinoma 329
Liver hypertrophy techniques: a position paper from the Italian Group of Regenerative and Occlusive Worldwide-used techniques of hepatic Hypertrophy (I GROWtoH) 315
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 310
Indocyanine Green Fluorescence-Guided Surgery for Gastrointestinal Tumors: A Systematic Review 307
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer 299
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients with Metabolic Syndrome 288
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study 271
Pancreaticojejunostomy Versus Neoprene-based Pancreatic Duct Occlusion in Pancreaticoduodenectomy for Patients at Intermediate-high Risk of Post-operative Pancreatic Fistula 268
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 264
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial) 261
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients 261
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 260
A Combined Approach to Priorities of Surgical Oncology During the COVID-19 Epidemic 252
Behaviour of the bowel wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn's disease : a prospective study 248
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis 247
The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors 247
Bowel ultrasound follow-up of Crohn disease after surgery allows the early identification of those patients at high risk of clinical or surgical recurrence 243
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma 233
Tremelimumab and durvalumab combination for the non-operative management (NOM) of microsatellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer : The multicentre, single-arm, multi-cohort, phase II INFINITY study 233
Reply to: Letter regarding 'Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma' 233
Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma 230
Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues 228
Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients. 225
Long-term outcome of patients undergoing resection versus transplantation for neuroendocrine liver metastases meeting the Milan Criteria 224
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 222
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis 220
Hepatocellular Carcinoma in Abernethy Malformation: A Rare Occurrence of Congenital Complete Portosystemic Shunt 220
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma 213
Serial US measurement of bowel wall thickness after conservative surgery is highly predictive of clinical or surgical recurrence in patients with Crohn's disease 206
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience 202
Portal vein arterialization for hepatic artery thrombosis in liver transplantation : a case report, Doppler-ultrasound aspects, and review of the literature 199
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors 197
Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series 195
Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads 193
Intrahepatic Flow Redistribution in Patients Treated with Radioembolization 191
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study 184
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 182
Resection of hepatocellular cancer ≤2 cm: results from two Western centers 181
Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma : a phase II study 180
Improved management of grade B biliary leaks after complex liver resections using gadoxetic acid disodium–enhanced magnetic resonance cholangiography 180
Innate immunity in colorectal liver metastases: macrophage morphology and distribution are strong predictors of prognosis: An external validation 172
Liver resection for perihilar cholangiocarcinoma :Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study 172
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma 171
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 171
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 169
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation : a proof of principle 168
Preoperative predictors of liver decompensation after mini-invasive liver resection 166
Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads: Clinical–Radiological Outcomes and Safety Profile 164
The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors : Pros and cons 163
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study 163
Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma 162
Radioembolization of hepatocarcinoma with 90Y glass microspheres : development of an individualized treatment planning strategy based on dosimetry and radiobiology 161
Hierarchic interaction of factors associated with liver decompensation after resection for hepatocellular carcinoma 161
ASO Visual Abstract: Impact of Surgical Margins on Overall Survival After Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series 160
The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review 159
Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective 157
Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma 157
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study 154
Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment 154
Repeated transarterial chemoembolization : an overfitting effort? 152
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma 152
Serial ultrasound measurement of bowel wall thickness after conservative surgery is highly predictive of clinical or surgical recurrence in patients with Crohn's disease 150
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres : the experience of the National Tumor Institute of Milan 150
Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative, Phase 2, Clinical Trial 144
ASO Visual Abstract: Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative Phase 2 Clinical Trial 144
Robotic vs laparoscopic resection for hepatocellular carcinoma: multicentric propensity-score matched analysis of surgical and oncologic outcomes in 647 patients 141
ASO Author Reflections: A Green Eye on Lymphadenectomy for Gastric Cancer 139
A snapshot on current approaches to lymphadenectomy in liver resection for intrahepatic cholangiocarcinoma: results from an international survey 138
Probability of Lymph Node Metastases in Patients Undergoing Adequate Lymphadenectomy during Surgery for Intrahepatic Cholangiocarcinoma: A Retrospective Multicenter Study 136
Strictureplasty in the surgical treatment of complicated Crohn's disease 136
Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma 134
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome 133
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma 133
The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients : reasons for a failure, and perspectives for the future 133
Correction to: Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 132
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome 131
Reply to: Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 130
External validation of an individual prognostic calculator after transarterial chemoembolization for hepatocellular carcinoma 128
Treatment of the Oligometastatic Patient 127
Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma 126
Cure after surgery for hepato-pancreato-biliary cancers: A systematic review 125
Pro (With Caution): Extended oncologic indications in liver transplantation 122
Effect of age on survival in patients undergoing resection of hepatocellular carcinoma 118
Reply 114
Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation 114
Intention-to-Treat Analysis of Hepatic Resection for Liver Metastases from Uveal Melanoma: A Single-Center Experience 111
Relative Survival Instead of Overall Survival Should Be Used as Outcome When Analyzing the Effect of Age After Treatment of Hepatocellular Carcinoma 109
Reply to: Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma 108
ASO Author Reflections: Less is more: Organ-Sparing Approach for the Surgical Treatment of Gastric Adenocarcinoma 105
Rescue pancreatic duct occlusion as pancreas-preserving procedure in case of emergency relaparotomy for grade C pancreatic fistulas after pancreaticoduodenectomy 99
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study 94
Reply to : sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue 93
Totale 21.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.164 61 56 43 101 90 79 60 60 167 121 76 250
2022/20231.480 148 131 98 168 161 235 74 88 173 29 112 63
2023/20243.636 54 74 138 96 182 144 576 506 254 473 561 578
2024/20254.335 591 563 492 416 287 183 137 330 201 270 340 525
2025/20267.885 578 953 687 558 595 512 758 351 694 541 820 838
2026/2027440 440 0 0 0 0 0 0 0 0 0 0 0
Totale 22.328